Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
The leap from academia to industry

The earlier in development, the greater the risk. It’s an unspoken law in biotech that makes valorizing promising academic projects difficult to f…


CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic ins…


After Ablynx, is an acquisition of Galapagos next?

The Gent biotech company Ablynx has been acquired by pharmaceutical giant Sanofi for 3.9 billion euros. The French Sanofi beat the Danish company …

POPULAR TAGS

Galapagos: Company of the Year

Written by DS on in the category news with the tags , .


The Mechelen-based Galapagos received yesterday in New York the award for company of the year by the Belgian-American Chamber of Commerce, Belcham. This happened at the annual gala of the organization.

Galapagos was chosen because it is an "excellent example of Belgian science and entrepreneurial spirit, reaching the top of the pharmaceutical industry in only a few years."

Read more about Galapagos here.

Read more about: , .

RELATED ARTICLES
The leap from academia to industry

The earlier in development, the greater the risk. It’s an unspoken law in biotech that makes valorizing promising academic projects difficult to f…


CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic ins…


After Ablynx, is an acquisition of Galapagos next?

The Gent biotech company Ablynx has been acquired by pharmaceutical giant Sanofi for 3.9 billion euros. The French Sanofi beat the Danish company …

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Turnstone Itera Life Science V-Bio Ventures KU Leuven UGent XpandInnovation Biowin GSK Flanders.bio Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.